Skip to content

Talinolol

CARDIOVASCULAR SYSTEM

Also known as: (+/-)-Talinolol, cordanum, racemic talinolol

ATC C07AB13

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Talinolol is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including ADRB1, ADRB2 and EPHX2. Recorded indications include Hypertensive disorder.

  • Molecular targets: ADRB1, ADRB2, EPHX2 and ABCB1 (4 listed in DrugCentral).
  • Indications: Hypertensive disorder.
  • ATC code: C07AB13 (Beta blocking agents, selective).
  • Molecular formula: C20H33N3O3; molecular weight 363.50 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Hypertensive disorder

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Beta-1 adrenergic receptorADRB1unknownKi 6.62
Beta-2 adrenergic receptorADRB2unknownKi 6.05
Bifunctional epoxide hydrolase 2EPHX2unknownIC50 5.55
Multidrug resistance protein 1ABCB1unknown—

ATC classification

ATC codeTherapeutic hierarchy
C07AB13CARDIOVASCULAR SYSTEM › BETA BLOCKING AGENTS › BETA BLOCKING AGENTS › Beta blocking agents, selective

Chemical structure

Molecular formulaC20H33N3O3
Molecular weight363.50 g/mol
CAS number57460-41-0
InChIKeyMXFWWQICDIZSOA-UHFFFAOYSA-N
PubChem CID68770
CC(C)(C)NCC(O)COC1=CC=C(NC(=O)NC2CCCCC2)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Talinolol used for?

DrugCentral lists the following indications for Talinolol: Hypertensive disorder.

How does Talinolol work?

Its molecular targets in DrugCentral include ADRB1, ADRB2, EPHX2 and ABCB1.

What is the chemical formula of Talinolol?

Talinolol has the molecular formula C20H33N3O3 and a molecular weight of 363.50 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets4
Indications1
FormulaC20H33N3O3
DrugCentral ID2557
Interactive profile